STICHTING TUBERCULOSIS VACCINE INITIATIVE - Netherlands 

Ranking results:

Past rankings:

2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2011
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2010
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2008
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 5
As coordinator: 2
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0.67*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2018 0 4.549.528 65.625 1
2015 18.200.000 0 2.473.986 1
2013 0 8.484.911 367.068 1
2011 0 29.980.670 193.000 1
2010 11.996.730 0 1.052.419 1

Networking:

Partners:

Institution:Projects [No]:
DEPARTMENT OF HEALTH4
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD4
ACADEMISCH ZIEKENHUIS LEIDEN3
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE3
GLAXOSMITHKLINE BIOLOGICALS3
INSTITUT PASTEUR3
ISTITUTO SUPERIORE DI SANITA3
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE3
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV3
STATENS SERUM INSTITUT3
UNIVERSITE DE GENEVE3
ASTON UNIVERSITY2
EDUCATIONAL FOUNDATION YONSEI UNIVERSITY2
FONDAZIONE PER L'ISTITUTO DI RICERC A IN BIOMEDICINA2
FOUNDATION BIOMEDICAL PRIMATE RESEARCH CENTRE2
FUNDACIO INSTITUT DE INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIAS I PUJOL2
HEALTH PROTECTION AGENCY2
HOOKIPA BIOTECH2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
INFECTIOUS DISEASE RESEARCH INSTITUTE2
INSTITUT PASTEUR DE LILLE2
INSTITUT SCIENTIFIQUE DE SANTE PUBLIQUE2
KING'S COLLEGE LONDON2
UNIVERSIDAD DE ZARAGOZA2
UNIVERSITAET ULM2
UNIVERSITAET ZUERICH2
UNIVERSITE DE LAUSANNE2
UNIVERSITE LIBRE DE BRUXELLES2
ABERA BIOSCIENCE AB1
AERAS GLOBAL TB VACCINE FOUNDATION1
ALL INDIA INSTITUTE OF MEDICAL SCIENCES1
ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRL ALTA1
ARCHIVEL FARMA SL1
ARENAVAX1
AZIENDA OSPEDALIERA UNIVERSITARIA POLICLINICO PAOLO GIACCONE DI PALERMO1
Bangor University1
BIONEEDLE TECHNOLOGIES GROUP BV1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
CROSSBETA BIOSCIENCES BV1
DUOTOL AB1
EATRIS ERIC1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH1
EMORY UNIVERSITY NON PROFIT CORP1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
ETNA BIOTECH1
FEDERAL STATE BUDGETARY EDUCATIONAL INSTITUTION OF HIGHER PROFESSIONAL EDUCTAION STATE UNIVERSITY OF MANAGEMENT1
FONDAZIONE HUMANITAS PER LA RICERCA1
FRIEDRICH LOEFFLER INSTITUT BUNDESFORSCHUNGSINSTITUT FUER TIERGESUNDHEIT1
GLAXOSMITHKLINE VACCINES1
GOETEBORGS UNIVERSITET1
GSK VACCINES INSTITUTE FOR GLOBAL HEALTH1
HOSPICES CANTONAUX CHUV1
ICOSAGEN AS1
INSTITUT PASTEUR KOREA1
INSTITUTO DE SALUD CARLOS III1
INTERCELL1
INTERNATIONAL TUBERCULOSIS RESEARCH CENTER1
INTERNATIONAL VACCINE INSTITUTE1
ISLENSK ERFDAGREINING EHF1
ISTITUTO NAZIONALE MALATTIE INFETTIVE LSPALLANZANI IRCCS1
JPT PEPTIDE TECHNOLOGIES1
KENYA MEDICAL RESEARCH INSTITUTE1
KWAZULU NATAL RESEARCH INSTITUTE FOR TBHIV NPC1
LEIDEN UNIVERSITY MEDICAL CENTER1
LIONEX1
MEDICAL RESEARCH COUNCIL1
MEDICINE IN NEED FRANCE ASSOCIATION1
MICROBIOTEC1
MINISTERIE VAN VOLKSGEZONDHEID WELZIJN EN SPORT1
NATIONAL CENTER FOR AIDS/STD CONTROL AND PREVENTION CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION1
OESTERREICHISCHE AKADEMIE DER WISSENSCHAFTEN1
PAUL EHRLICH INSTITUT1
PEVION BIOTECH1
POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNG1
PX'THERAPEUTICS1
REITHERA1
SCLAVO VACCINES ASSOCIATION1
SEATTLE BIOMEDICAL RESEARCH INSTITUTE NON PROFIT CORPORATION1
SIGMOID PHARMA LIMITED1
ST GEORGE'S HOSPITAL MEDICAL SCHOOL1
STELLENBOSCH UNIVERSITY1
STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK1
STICHTING EATRIS1
THE DI IVANOVSKY INSTITUTE OF VIROLOGY OF THE MINISTRY OF THE HEALTHOF THE RUSSIAN FEDERATION1
THE SECRETARY OF STATE FOR ENVIRONMENT FOOD AND RURAL AFFAIRS1
THE UNIVERSITY OF SHEFFIELD1
THE UNIVERSITY OF SYDNEY1
TRANSGENE1
UNIVERSITA DEGLI STUDI DI CATANIA1
UNIVERSITA DEGLI STUDI DI PADOVA1
UNIVERSITA DEGLI STUDI DI PALERMO1
UNIVERSITA DEGLI STUDI DI SIENA1
UNIVERSITAET BASEL1
UNIVERSITAET INNSBRUCK1
UNIVERSITATSKLINIKUM ERLANGEN1
UNIVERSITEIT GENT1
UNIVERSITEIT UTRECHT1
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN1
UNIVERSITY HOSPITAL BASEL1

Constancy:

Total number of partners: 152
Partner loyalty:
Frequent Partner: (> 2 projects): 35
Rare Partner: 117
Frequent / Rare Partner Ratio: 0.3

Project overview:

Start dateProjectacronymrolefundingpartners
2018-02-01In Silico Trial for Tuberculosis Vaccine Development STriTuVaDparticipant4.549.5288
2015-01-01TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development TBVAC2020coordinator18.200.00044
2013-11-01European Research Infrastructures for Poverty Related Diseases EURIPREDparticipant8.484.91118
2011-10-01Advanced Immunization Technologies ADITECparticipant29.980.67052
2010-01-01Discovery and preclinical development of new generation tuberculosis vaccines NEWTBVACcoordinator11.996.73035